Virupaksha Organics Ltd.: A Leading Producer of Fexofenadine HCl

Virupaksha Organics Ltd. has solidified its position as a key player in the global pharmaceutical industry, particularly in the production of Fexofenadine Hydrochloride (HCl), a widely used antihistamine for treating allergy symptoms. With cutting-edge manufacturing facilities in Telangana, India, Virupaksha adheres to the highest international standards of quality and compliance, ensuring the production of top-quality Fexofenadine HCl for both domestic and international markets.
Virupaksha’s facilities are certified by WHO-GMP, ISO 9001, and ISO 14001, which attests to the company’s commitment to maintaining rigorous quality control and environmental management. The company’s production capabilities and advanced R&D enable it to deliver cost-effective, high-purity APIs that meet the growing global demand for Fexofenadine HCl.
With its focus on innovation, sustainability, and customer satisfaction, Virupaksha Organics continues to be a trusted partner for pharmaceutical companies worldwide. Its strategic approach to producing APIs like Fexofenadine HCl positions the company as a leader in the antihistamine market, contributing to improved healthcare outcomes for millions of patients globally.
As the demand for allergy medications rises, Virupaksha Organics remains at the forefront of API production, demonstrating excellence in pharmaceutical manufacturing and reinforcing its status as a premier producer of Fexofenadine HCl.

Other Latest News
- Sensex tanks 550 pts, Nifty 50 slips below 24,800 mark as tariff worries hit banking, pharma, metal stocks August 26, 2025 8:39 am The Hindu Business Line Equity benchmark indices witnessed a sharp downturn as escalating global trade tensions weighed heavily on investor sentiment. The US issued a draft notice over the implementation of an additional 25 per cent tariff on Indian imports. Both the Sensex and …
- Big pharma bet: Jefferies lists out India’s next CRDMO multibaggers with up to 37% upside potential August 26, 2025 8:31 am Financial Express The CRDMO industry (Contract Research, Development, and Manufacturing Organization) in India has evolved from being perceived as quasi-chemical firms till a few years ago to one of the important subsets of the overall pharma sector. They are emerging as …
- Sun Pharma, Lupin, Dr Reddy’s Drop Up To 4% As Trump’s Pharma Shock Spooks Investors August 26, 2025 8:25 am News18 Last Updated:August 26, 2025, 12:09 IST Indian pharmaceutical stocks slipped sharply on Tuesday after US President Donald Trump vowed to slash drug prices Pharma Stocks SlipPharma stocks tumbled on Tuesday after US President Donald Trump vowed to slash …
- Powering pharma's digital leap with intelligent identity management August 26, 2025 7:41 am Pharmabiz.com In 2020, the Covid-19 pandemic accelerated the digital transformation of India’s pharmaceutical sector. Factories ran round the clock, research teams pushed boundaries, and digital platforms became the connective tissue between labs and logistics. This …
- Calluna Pharma Announces Initiation of Phase 2 AURORA Study of CAL101 for Idiopathic Pulmonary Fibrosis August 26, 2025 7:14 am The AI Journal CAL101 is a first-in-class monoclonal antibody targeting S100A4, a damage-associated molecular pattern (DAMP) protein associated with serious and life-threatening fibrotic disorders Phase 2 AURORA study of CAL101 designed to prevent lung function decline …
- Pharma stocks take a hit as Trump issues fresh warning; key details August 26, 2025 6:30 am Business Today Pharma stocks tumbled on Tuesday after the US President Donald Trump vowed to slash drug prices in the US by an unprecedented 1,400–1,500 per cent, (practically not possible below 100 per cent), a move that could render exports to the US uncompetitive. …
- US issues draft notice to enforce 50% tariffs on India from Aug. 27; Pharma, electronics exempted August 26, 2025 6:30 am The New Indian Express The Commerce Ministry has assured exporters that the government will take all possible measures to safeguard them from the ongoing global uncertainties. However, the Indian government hasn't come up with any retaliatory measures so far against the US. …
- Indian Stock Markets Slide Amid Tariff Worries And Weak Global Sentiment August 26, 2025 5:31 am Zee News New Delhi: Indian benchmark indices tumbled near their intraday lows on Tuesday as global sentiment weakened ahead of new US tariffs scheduled to take effect from Wednesday. The BSE Sensex fell 672 points (0.82 percent) to 80,964, while the NSE Nifty50 …
- India Stock Market: Nifty Slips Under 24,900 As Pharma Stocks Lead The Drag August 26, 2025 5:21 am myMotherLode – California Textile stocks were also under pressure as Trump’s 50% tariffs on Indian exports kick in from Wednesday Indian markets opened lower on Tuesday, with the Nifty50 index failing to hold the crucial 24,900 in early trade. Every major index, bar FMCG, was …
- Liberia: Heaven Eleven, Global Pharma, and Freeport FC Off to Winning Starts in Bettomax Champions Cup August 26, 2025 4:52 am Front Page Africa With eight clubs in contention for the prestigious US$10,000 grand prize and the giant-sized trophy, the tournament’s opening round set an early tone as teams battled to establish their footing in the group stage. Monrovia – The 2025 edition of the …
- Daewoong signs $24.5 mil. Nabota export deal with Colombia’s Valentech Pharma August 26, 2025 3:45 am Korea Biomedical Review Daewoong Pharmaceutical announced Tuesday that it has signed a 34.1 billion won ($24.5 million) export agreement with Colombian drugmaker Valentech Pharma for its botulinum toxin, Nabota, thereby strengthening the product’s foothold in Latin America. The …
- Indian biotech & pharma sectors adopt virtual transformation as cloud─powered trials redefine clinical research August 26, 2025 3:15 am Pharmabiz.com Indian biotech and pharma industries are looking for more efficient, accessible, and resilient operations. This shift is driven by the strategic integration of virtual environments, cloud computing, and advanced security solution like Zero Trust, said …
- Insights from Vyome on Building a Global Biotech Network August 25, 2025 11:43 pm Pharmaceutical Executive In a recent interview with Pharmaceutical Executive, Shiladitya Sengupta, founder of Vyome Therapeutics, discussed the company’s strategic decision to go public through a reverse merger with Reshape Life Sciences, its approach to engaging US investors …
- Advanz Pharma, Alvotech receive European approval for Mynzepli, biosimilar to Eylea August 25, 2025 9:22 pm Drug Store News Alvotech and Advanz Pharma, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital and rare disease medicines in Europe, announced that the European Commission has approved Mynzepli as a biosimilar to Eylea ( …
- Pharma exporters body wants GST rates on APIs, formulations aligned August 25, 2025 7:15 pm The Hindu Ahead of the Goods and Services Tax (GST) Council meet early next month in which the two-rate structure proposed is expected to be discussed, pharma exporters’ body Pharmexcil has appealed for aligning of GST on active pharmaceutical ingredients (APIs) and …
- Akums, Zambia Govt form JV to set up pharma manufacturing facility August 25, 2025 6:21 pm The Hindu Business Line Sanjeev Jain, Managing Director at Akums Akums, a leading player in pharmaceutical manufacturing, and the Government of the Republic of Zambia (GRZ) have announced a partnership to establish a manufacturing facility in Zambia, providing high-quality and …
- Global Oral Thin Films Market Valued at USD 3.8 Billion in 2024 to Cross USD 9.0 Billion by 2035 – Analysis by TMR August 25, 2025 6:00 pm EIN Presswire Oral Thin Films Industry to Expand Nearly 2.5 Times from USD 3.8 Billion in 2024 to USD 9.0 Billion by 2035 | Latest Report by Transparency Market Research Inc WILMINGTON, DE, UNITED STATES, August 25, 2025 /EINPresswire.com/ — Market Size- …
- [Latest] Global Chemical Reagents Market Size/Share Worth USD 26.5 Billion by 2034 at a 7.5 CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) August 25, 2025 4:30 pm EIN Presswire Austin, TX, USA, Aug. 25, 2025 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled “Chemical Reagents Market Size, Trends and Insights By Product Type (Solvents, Acids & Bases, Oxidizing & Reducing Agents, Buffers …
- Sensex rebounds 329 pts on rally in IT shares, global cues amid US Fed rate cut hopes August 25, 2025 3:50 pm ETBFSI.com Sensex rebounds 329 pts on rally in IT shares, global cues amid US Fed rate cut hopes Mumbai, Benchmark BSE Sensex rebounded by 329 points on Monday following heavy buying in IT and auto shares and a rally in global equity markets on hopes of a potential …
- Crimp Neck Serum Bottles Market to Hit USD 2.4 billion by 2035, Driven by Pharma and Cosmetic Packaging Demand August 25, 2025 3:45 pm EIN Presswire Global Crimp Neck Serum Bottles Market to grow at 5.0% CAGR, led by glass bottles, pharma demand, and innovation from key manufacturers. NEWARK, DE, UNITED STATES, August 25, 2025 /EINPresswire.com/ — The global Crimp Neck Serum Bottles Market, …
- Nifty, Sensex Recover on Global Cues – Monday Market Report August 25, 2025 2:14 pm Moneylife India On Monday, 1948 stocks advanced, 2237 declined and 210 remained unchanged on Bombay Stock Exchange with advance decline ratio of 0.87 indicating a negative closing. Moneylife’s Market Breadth Indicators remain neutral. The trend of the major indices on …
- Reverse Cap Bottles Market to Reach USD 4.7 billion by 2035, Driven by Cannabis, Pharma, and Sustainable Packaging August 25, 2025 2:00 pm EIN Presswire The Reverse Cap Bottles Market is set to grow at 4.0% CAGR, fueled by cannabis, pharma demand, and new innovations from global manufacturers. NEWARK, DE, UNITED STATES, August 25, 2025 /EINPresswire.com/ — The global reverse cap bottles market, …
- Piramal Pharma opens oral solid dosage suite in Pennsylvania, US August 25, 2025 1:40 pm Pharmaceutical Business Review Piramal Pharma Solutions and NewAmsterdam Pharma have announced the inauguration of an oral solid dosage (OSD) suite at the former’s facility located in Sellersville, Pennsylvania, US. The investment equips NewAmsterdam Pharma with the commercial …
- Pet Probiotics Market to Reach $7.1 Billion by 2031 | Growth Driven by Humanization & Gut Health Awareness August 25, 2025 1:00 pm EIN Presswire Global pet probiotics market set to reach $7.1B by 2031, fueled by pet humanization, gut health awareness & preventive care trends. AUSTIN, TX, UNITED STATES, August 25, 2025 /EINPresswire.com/ — The pet probiotics market has emerged as a …
- Global Suppositories Market to Surpass USD 2.05 Billion by 2030 | MarketsandMarkets™ August 25, 2025 12:45 pm EIN Presswire Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) — The global suppositories market, valued at US$1.56 billion in 2024, stood at US$1.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.7% from 2025 to 2030, culminating in a forecasted …